The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.
Posted by UE editors
Click to copy the Short Url to this post:
The Whole Web on a Single Page, and a Community for People Who Love Good Reads. Join Us →